Short Communication

Cancer stem cells in melanoma

1 Dec 2008
C Regenbrecht, Y Welte, R Hugel, U Trefzer, FO Losch, P Walden, J Adjaye

To avoid artefacts introduced by culturing cells for extended periods of time, it is crucial to use low-passage patient-derived tumour cells. The ability to enrich, isolate and assay sub-populations of cells that behave as cancer stem cells (CSCs) from these primary cell lines is essential before performing characterisations such as gene-expression profiling. We have isolated cells from glioblastomas which show characteristics of CSCs. Although glioblastomas contain only a relatively small amount of putative CSCs, these cells express many genes which seem to be worthy targets for future therapies.

Please note: an Erratum has been published for this article ecancer 6 249 (2012)

Related Articles

Uchenna Simon Ezenkwa, Gabriel Olabiyi Ogun, Mbwas Isaac Mashor, Olufemi John Ogunbiyi
Manju Sengar, Wilma M Hopman, Ghulam Rehman Mohyuddin, Aaron M Goodman, Bishal Gyawali, Deborah Mukherji, Nazik Hammad, CS Pramesh, Ajay Aggarwal, Richard Sullivan, Christopher M Booth
Subramaniam Ramanathan, Sneha Sisodiya, Omshree Shetty, Maya Prasad, Badira C Parambil, Sneha Shah, Mukta Ramadwar, Nehal Khanna, Siddhartha Laskar, Sajid Qureshi, Tushar Vora, Girish Chinnaswamy
Uchenna Simon Ezenkwa, Mohammed Ibrahim Imam, Maimuna Orahachi Yusuf, Abdullahi Sani Giade, Iragbogie Al-Mustapha Imoudu, Dauda Abubakar Katagum, Bala Muhammad Audu